Mitchell Ho
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Immunology top 1%
- Immunotherapy and Immune Responses
- Toxin Mechanisms and Immunotoxins
Papers in
- Oncology 58
- CAR-T cell therapy research 48
-
- Monoclonal and Polyclonal Antibodies Research 54
- Co-authors
- Ira Pastan (29 shared papers)Raffit Hassan (17 shared papers)Wei Gao (18 shared papers)Heungnam Kim (7 shared papers)Mingqian Feng (17 shared papers)Yu‐suke Torisawa (2 shared papers)Shuichi Takayama (2 shared papers)Steven G. Allen (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (8 papers)Clinical Cancer Research (8 papers)Cancer Research (7 papers)Scientific Reports (6 papers)mAbs (5 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Mitchell Ho
135 papers receiving 6.6k citations
Mitchell Ho's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 2.0k
- Immunology 1.5k
- Biotechnology 570
- Hepatology 458
- Radiology, Nuclear Medicine and Imaging 1.3k
Countries citing papers authored by Mitchell Ho
This map shows the geographic impact of Mitchell Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Ho more than expected).
Fields of papers citing papers by Mitchell Ho
This network shows the impact of papers produced by Mitchell Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Ho. The network helps show where Mitchell Ho may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array Hit paper breakdown → | 2010 | 764 |
| 2 | 2006 | 321 | |
| 3 | 2007 | 268 | |
| 4 | 2012 | 186 | |
| 5 | 2010 | 182 | |
| 6 | 2013 | 160 | |
| 7 | 2008 | 150 | |
| 8 | 2006 | 140 | |
| 9 | 2014 | 139 | |
| 10 | Cancer therapy with antibodies Hit paper breakdown → | 2024 | 128 |
| 11 | 2015 | 125 | |
| 12 | 2005 | 122 | |
| 13 | 2007 | 115 | |
| 14 | 2018 | 114 | |
| 15 | 2013 | 105 | |
| 16 | 2018 | 101 | |
| 17 | 2017 | 98 | |
| 18 | 2013 | 93 | |
| 19 | 2019 | 92 | |
| 20 | 2007 | 88 |
About Mitchell Ho
Mitchell Ho is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology and Biotechnology, having authored 145 papers that have together received 6.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (54 papers), CAR-T cell therapy research (48 papers), Toxin Mechanisms and Immunotoxins (26 papers), Glycosylation and Glycoproteins Research (25 papers), Occupational and environmental lung diseases (16 papers), Proteoglycans and glycosaminoglycans research (11 papers), Immunotherapy and Immune Responses (9 papers) and Neuroblastoma Research and Treatments (8 papers). The work is most often cited by research in Oncology (2.0k citations), Immunology (1.5k citations), Biotechnology (570 citations), Hepatology (458 citations) and Radiology, Nuclear Medicine and Imaging (1.3k citations). Mitchell Ho has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Ira Pastan, Raffit Hassan, Wei Gao, Heungnam Kim, Mingqian Feng, Yu‐suke Torisawa, Shuichi Takayama, Steven G. Allen, Amy Y. Hsiao and Yi‐Chung Tung. Their work appears in journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research, Cancer Research, Scientific Reports and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.